Massive Bio Partners with FOMAT to Expand Cancer Patient Prescreening for Clinical Trial Access
Massive Bio partners with FOMAT, the largest U.S. Embedded Research Organization, to launch AI-powered cancer patient prescreening for clinical trials. BOCA RATON, FL, UNITED STATES, July 20, 2026 /EINPresswire.com/ -- Massive Bio, a global precision …